Bone Loss Completed Phase 1 Trials for Teriparatide (DB06285)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00277706Impact of Parathyroid Hormone (PTH) on Osseous CavityTreatment